
A Swedish study of 51 patients with HPV-positive head and neck cancers found that circulating tumour HPV DNA (ctHPV-DNA) levels correlated with tumour and nodal volume. At follow-up, undetectable ctHPV-DNA aligned with positive radiological outcomes. The findings support ctHPV-DNA as a promising biomarker for treatment evaluation and recurrence monitoring.
Like
Save
Share